ALKBH5 and non-small cell lung carcinoma: These data indicated that catabolism of BCAAs leads to changes in intracellular α-KG levels, which further regulate the malignant proliferation of NSCLC cells through epigenetic regulation of gene expression via ALKBH5 modification.